Changdong Liu, M.D. is currently the Chief Medical Officer (CMO) & Chief Scientific Officer (CSO) at Ocumension, a company listed on the Hong Kong Stock Exchange. Previously, Changdong held key positions at Livzon Mabpharm, Inc., Qilu Pharmaceutical Co., Ltd., Bio-Thera Solutions, and Alcon, gaining extensive experience in clinical development and clinical trial operations. With a strong educational background in biological and biomedical sciences, clinical medicine, ophthalmology, and cancer research, Changdong has a solid foundation for their leadership roles in the pharmaceutical industry.
2018 - present
Managing Director, Executive Search at Robert Half
VP, Marketing & High School Programs at Greenheart International
Global Head Of Process Optimization, Enterprise Operations at Northern Trust
VP Marketing Strategy at ecobee
Digital Marketing Specialist at Parablu
Access the worlds's biggest network of public org charts
Learn more